HONORHEALTH SCOTTSDALE OSBORN MED CT — History
CCN 030038 | 3-year financial timeline | COVID resilience: 62/100
🛡️ Public data only — no PHI permitted on this instance.
$440M
Latest Revenue (FY2022)
+8.6%
Revenue CAGR (3yr)
0.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $373M | $427M | $440M | +3.0% | +8.6% |
| Operating Expenses | $372M | $418M | $437M | +4.4% | +8.4% |
| Operating Margin | 0.3% | 2.1% | 0.8% | -62.1% | +65.0% |
| Net Income | $1M | $9M | $3M | -60.9% | +79.2% |
| Licensed Beds | 337 | 337 | 337 | +0.0% | +0.0% |
| Total Patient Days | 66,357 | 67,274 | 67,385 | +0.2% | +0.8% |
| Medicare Day % | 30% | 30% | 30% | +0.9% | +1.1% |
| Medicaid Day % | 22% | 24% | 21% | -10.0% | -1.2% |
COVID Impact & Recovery
Resilience Score: 62/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +18.0% ($373M → $440M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+8.6%
This Hospital
+7.6%
State Avg
Latest Margin
0.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $474M | 1.0% |
| FY2024 (proj) | $507M | 1.3% |
| FY2025 (proj) | $541M | 1.5% |